Kidney Transplant Medication - enteric-coated myfortic mycophenolic acid delayed-release tablet














 

Featured Click - Quiz: How are you feeling?
  Novartis Pharma US

 
Treatment Options


Treatment Options:
myfortic® and CellCept®


myfortic and CellCept contain the same active ingredient and work equally well to help keep your body from rejecting your new kidney. The difference is a protective coating on every myfortic tablet. It's called an enteric coating and it's only available on myfortic. This section explains the value of the enteric coating. It also has information about myfortic and CellCept that you may want to discuss with your doctor or transplant team.

Start here to learn about your treatment options.
About myfortic and CellCept >>

myfortic delayed-release tablets and CellCept (mycophenolate mofetil) tablets and capsules should not be used interchangeably without physician supervision because the speed at which your body absorbs these two products is not the same.

Click here for complete prescribing information, which includes contraindications, warnings, precautions, and adverse events.

Back to top 




CellCept® is a registered trademark of Roche Laboratories, Inc.

myfortic Home | Before a Kidney Transplant | After a Kidney Transplant Treatment Options: myfortic and CellCept | Life With myfortic | More Transplant Resources Prescribing Information | Important Safety Information | For Healthcare Professionals Glossary | Site Guide | Site Map | Contact Us
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.